Framework Chewable Wafers
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80035932
- Status
- Active licence
- Licence date
- 27 September 2012
- Revision date
- Not provided
- Form
- Gaufrette
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Calcium glycinate | 4.05 mg | Not calculated |
| Calcium Source : Lithothamnion corallioides - En entier | 7.5 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 245 mg | Not calculated |
| Calcium Source : Citrate malate de calcium | 4.5 mg | Not calculated |
| Pueraria lobata Source : Root extract (standardised) Potency : 40 % Isoflavones | 35 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 75 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 2 mg | Not calculated |
| Equisetum arvense Source : Grass standardized extract Potency : 7 % Silica | 25 mg | Not calculated |
| Magnésium Source : Glycinate de magnésium | 3 mg | Not calculated |
| Glycine max Source : Extrait normalisé de fève soja | Not specified | Not calculated |
| Boron Source : Citrate de bore | 1,500 mcg | Not calculated |
| Trifolium pratense Source : Fleur | 2.5 mg | Not calculated |
Non-medicinal ingredients
Saveurs naturelles, Acide stéarique, silice, Huile de noix de coco, Cane sugar, Fruit juice concentrate, Acide citrique, Stéarate de magnésium végétal, acide malique, Carmine red, Feuille de stévia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 wafer | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80035932
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.